Dawon Medax
PrivateLast Round
Growth Equity
Feb 6, 2026
Total Funding Raised
$39.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dawon Medax operates in Healthcare & Life Sciences and is based in Incheon. Its latest recorded funding round was a Series B round in September 2019.
Dawon Medax is a biotechnology company that develops boron neutron capture therapy (BNCT) systems and related radiopharmaceuticals for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dawon Medax Comparables
Compare Dawon Medax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TAE Life Sciences | 89% | |
| Neutron Therapeutics | 89% | |
| Neuboron Medical Group | 87% |
For institutional investors. Book with your work email.
Dawon Medax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Feb 6, 2026 | ||||
| Series B | Sep 1, 2019 | ||||
| Series A | Dec 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dawon Medax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series A |
| KDB Capital Corp | Series A |
| Ministry of Trade, Industry and Energy | Grant |
| BNK Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 34% MoM, reaching 230.
- Feb 6, 2026
Raised $29M in Growth Equity funding.
For institutional investors. Book with your work email.
Dawon Medax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dawon Medax's valuation, stock price, and market status.
Is Dawon Medax a public or private company?
Dawon Medax is a private company.
What is the current stock price of Dawon Medax?
Dawon Medax is a private company, so its shares have no public market price. Caplight tracks Dawon Medax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dawon Medax worth (valuation)?
Valuation information for Dawon Medax is not publicly available.
Can I buy Dawon Medax stock?
Dawon Medax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dawon Medax's last funding round?
Dawon Medax's most recent funding round was Growth Equity on February 6, 2026.
Who are the main investors in Dawon Medax?
Key investors in Dawon Medax include SV Investment, KDB Capital Corp, Ministry of Trade, Industry and Energy, BNK Ventures.
Will Dawon Medax IPO soon?
No public IPO plans have been announced for Dawon Medax.
How can I track Dawon Medax secondary market activity?
Caplight tracks bids, offers, and trades in Dawon Medax's shares on secondary markets.